A Safety and Efficacy Study of SABER®-Bupivacaine for Pain Following Hernia Repair

Inclusion Criteria: * Males and females, 18 to 65 years of age, scheduled for hernia repair surgery * Patients must be in good health prior to study participation * Patients must have blood pressure within normal range or with Stage 1 high blood pressure * Male and female patients must agree to use medically acceptable method of contraception throughout the entire trial period and for 1 week after the trial is completed * Patients must refrain from strenuous activities and avoid changes to prescribed exercise levels throughout the course of the trial * Ability to read, understand, communicate, and voluntarily sign the informed consent form prior to any trial specific procedures Exclusion Criteria: * Patients with previous abdominal surgery scar tissue * Patients with clinically significant abnormalities of any body system unrelated to the disease under study * Connective tissue disorders * Patients who are pregnant or lactating * Current or regular use of analgesic medication for other indications * Patients with current or regular use of antidepressants or monoamine oxidase inhibitors at screening * Use of any drugs or medication that may interfere with the study and its results * Patients with known hypersensitivity to the study drugs or their components * Patients with known or suspected alcohol abuse or illicit drug use * Participation in another clinical trial at the same time or within 30 days of this trial * Patient is unwilling to comply with the study procedures